Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats.

The male pubertal onset assay has been recommended by the Endocrine Disrupter Screening and Testing Advisory Committee (EDSTAC) as an alternate Tier I screening assay to detect potential endocrine-active chemicals (EACs). Recently, this assay was evaluated by several laboratories using a variety of dosing schemes. This study used a 30-day dosing period to confirm and extend previous work on the assay's ability to detect steroid biosynthesis inhibitors. Weanling male rats were dosed by gavage from 21 to 50 days of age with vehicle (0.5% methocel) or chemicals from the following EAC classes: an androgen (testosterone propionate [TP], 0.1 or 0.4 mg/kg/day), a broad-spectrum steroid biosynthesis inhibitor (ketoconazole [KETO], 24 mg/kg/day), a 5alpha-reductase inhibitor (finasteride [FIN], 20 or 80 mg/kg/day), a moderately specific aromatase inhibitor (testolactone [TL], 220 mg/kg/day), or a highly specific aromatase inhibitor (fadrozole [FAD], 0.6 or 6.0 mg/kg/day). None of these treatments altered relative thyroid weights. However, TL, KETO, and FIN were positive for endocrine activity based on decreases in one or more reproductive or accessory sex gland organ weights. Of these three inhibitors, only TL significantly increased the age at PPS, indicating that PPS was less sensitive for detecting these EACs. Based on its profile of effects, TL may have been detected as an antiandrogen. TP and FAD were negative in this assay, even at doses that caused effects in other studies. With TP, oral administration limited assay sensitivity such that higher TP doses would be needed for detection. FAD decreased body weight gains, but did not significantly alter any other assay end points; thus, the capacity of this assay to detect aromatase inhibitors remains in question.

[1]  B. J. Winer Statistical Principles in Experimental Design , 1992 .

[2]  I. Huhtaniemi,et al.  Preputial separation as an external sign of pubertal development in the male rat. , 1977, Biology of reproduction.

[3]  R. Vigersky,et al.  The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol. , 1982, Endocrinology.

[4]  B. S. Setty,et al.  Effect of flutamide, a nonsteroidal antiandrogen on functional maturation of the epididymis of rat. , 2009, Experimental and clinical endocrinology.

[5]  J. Trachtenberg The effects of ketoconazole on testosterone production and normal and malignant androgen dependent tissues of the adult rat. , 1984, The Journal of urology.

[6]  A. Vawda,et al.  An investigation into the effects of ketoconazole on testicular function in Wistar rats. , 1986, Acta endocrinologica.

[7]  S. Santner,et al.  Inhibition of testosterone production with ketoconazole alone and in combination with a gonadotropin releasing hormone analogue in the rat. , 1986, Cancer research.

[8]  J. Freitag,et al.  Differential effects of chronic testosterone treatment on the onset of puberty in male rats. , 2009, Experimental and clinical endocrinology.

[9]  J. D. Neill,et al.  The Physiology of reproduction , 1988 .

[10]  L. Johnson,et al.  The effect of a 5 alpha-reductase inhibitor on androgen physiology in the immature male rat. , 1989, Endocrinology.

[11]  L. Johnson,et al.  The Effect of a 5α-Reductase Inhibitor on Androgen Physiology in the Immature Male Rat* , 1989 .

[12]  B. S. Setty,et al.  Effect of a nonsteroidal antiandrogen, anandron, on the reproductive system and fertility in male rats. , 1990, Contraception.

[13]  B. S. Setty,et al.  Changes in testis, epididymis and other accessory organs of male rats treated with anandron during sexual maturation. , 1990, Endocrine research.

[14]  G. Irsy,et al.  Neuroendocrinological effects of ketoconazole in rats. , 1990, Acta endocrinologica.

[15]  R. Robertson,et al.  Reversible decreases of fertility in male Sprague-Dawley rats treated orally with finasteride, a 5 alpha-reductase inhibitor. , 1991, Reproductive toxicology.

[16]  G. -. Zhang,et al.  Pharmacokinetic and pharmacodynamic studies of the effect of ketoconazole on reproductive function in male rats. , 1992, International journal of andrology.

[17]  J. Cook,et al.  Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats. , 1993, Toxicology and applied pharmacology.

[18]  V. Chandrashekar,et al.  Maintenance of sexual function with testosterone in the gonadotropin-releasing hormone-immunized hypogonadotropic infertile male rat. , 1993, Biology of reproduction.

[19]  A. Panzeri,et al.  Hormonal effects of turosteride, a 5α-reductase inhibitor, in the rat , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  A. Panzeri,et al.  Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat. , 1993, The Journal of steroid biochemistry and molecular biology.

[21]  CGP 53153: a new potent inhibitor of 5α-reductase , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  M. Biollaz,et al.  CGP 53153: a new potent inhibitor of 5alpha-reductase. , 1996, The Journal of steroid biochemistry and molecular biology.

[23]  J. Malley,et al.  Recovery of reproductive function in rats treated with the aromatase inhibitor fadrozole. , 1996, Reproductive toxicology.

[24]  M. Dukes,et al.  The preclinical pharmacology of “Arimidex” (Anastrozole; ZD1033) — a potent, selective aromatase inhibitor , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  E. Wilson,et al.  Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications , 1997, Journal of Molecular Medicine.

[26]  J. Ashby,et al.  The weanling male rat as an assay for endocrine disruption: preliminary observations. , 1997, Regulatory toxicology and pharmacology : RTP.

[27]  L. G. Davis,et al.  Development of a Tier I screening battery for detecting endocrine-active compounds (EACs). , 1997, Regulatory toxicology and pharmacology : RTP.

[28]  D. Vanderschueren,et al.  Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. , 1997 .

[29]  L. G. Davis,et al.  An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs). , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  E W Carney,et al.  Evaluation of the EDSTAC female pubertal assay in CD rats using 17beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  E Monosson,et al.  Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat , 1999, Toxicology and industrial health.

[32]  L. Gray,et al.  Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat , 1999, Toxicology and industrial health.

[33]  J Ashby,et al.  The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti‐androgens, oestrogens and metabolic modulators , 2000, Journal of applied toxicology : JAT.

[34]  L. G. Davis,et al.  Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  L. Gray,et al.  Endocrine-Disrupting Chemicals: Prepubertal Exposures and Effects on Sexual Maturation and Thyroid Function in the Male Rat. A Focus on the EDSTAC Recommendations , 2000, Critical reviews in toxicology.

[36]  E W Carney,et al.  Evaluation of the male pubertal assay's ability to detect thyroid inhibitors and dopaminergic agents. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.